| Greenhaven Health And Rehabilitation Center | |
| 801 Greenhaven Drive, Greensboro, North Carolina 27406 | |
| (336) 292-8371 | |
| Name | Greenhaven Health And Rehabilitation Center |
|---|---|
| Location | 801 Greenhaven Drive, Greensboro, North Carolina |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 120 |
| Occupancy Rate | 55.83% |
| Medicare ID (CCN) | 345132 |
| Legal Business Name | Snowshoe Ltc Group, Llc |
| Ownership Type | Non Profit - Corporation |
| NPI Number | 1619908977 |
| Organization Name | SNOWSHOE LTC GROUP, LLC |
| Doing Business As | GREENHAVEN HEALTH AND REHABILITATION CENTER |
| Address | 801 Greenhaven Dr, Greensboro, NC 27406 |
| Phone Number | 336-292-8371 |
News Archive
Researchers at the University of Hawai'i Cancer Center have uncovered a novel mechanism that may lead to more selective ways to stop cancer cells from spreading. Associate Professor Joe W. Ramos PhD, a cancer biologist at the UH Cancer Center and his team have identified the role of the protein RSK2 in cancer cell migration, part of the process of cancer metastasis.
Elevated cholesterol levels in midlife - even levels considered only borderline elevated - significantly increase the risk of Alzheimer's disease and vascular dementia later in life, according to a new study by researchers at Kaiser Permanente's Division of Research and the University of Kuopio in Finland. The study appears in the journal Dementia & Geriatric Cognitive Disorders.
The range of biomimetic approaches to promote bone growth that are at the core of current bone healing therapies need to more closely emulate natural regenerative mechanisms.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), and TransDerm, Inc., a biopharmaceutical company developing nucleic acid skin delivery technologies and therapeutics for skin disorders, announced today that they will collaborate on studying the potential utility of RXi's proprietary compounds in dermatology models.
› Verified 6 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Researchers at the University of Hawai'i Cancer Center have uncovered a novel mechanism that may lead to more selective ways to stop cancer cells from spreading. Associate Professor Joe W. Ramos PhD, a cancer biologist at the UH Cancer Center and his team have identified the role of the protein RSK2 in cancer cell migration, part of the process of cancer metastasis.
Elevated cholesterol levels in midlife - even levels considered only borderline elevated - significantly increase the risk of Alzheimer's disease and vascular dementia later in life, according to a new study by researchers at Kaiser Permanente's Division of Research and the University of Kuopio in Finland. The study appears in the journal Dementia & Geriatric Cognitive Disorders.
The range of biomimetic approaches to promote bone growth that are at the core of current bone healing therapies need to more closely emulate natural regenerative mechanisms.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), and TransDerm, Inc., a biopharmaceutical company developing nucleic acid skin delivery technologies and therapeutics for skin disorders, announced today that they will collaborate on studying the potential utility of RXi's proprietary compounds in dermatology models.
› Verified 6 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 2 |
| Total Amount of Fines in Dollars | $73166 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 2 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 21.54 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 6.61 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 29.41 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 1.03 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 4.55 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 59.42 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 9.42 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 33.06 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 2.78 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 28.38 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 22.46 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 10.27 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 85.88 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 82.38 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 38.86 | 82.93 |
News Archive
Researchers at the University of Hawai'i Cancer Center have uncovered a novel mechanism that may lead to more selective ways to stop cancer cells from spreading. Associate Professor Joe W. Ramos PhD, a cancer biologist at the UH Cancer Center and his team have identified the role of the protein RSK2 in cancer cell migration, part of the process of cancer metastasis.
Elevated cholesterol levels in midlife - even levels considered only borderline elevated - significantly increase the risk of Alzheimer's disease and vascular dementia later in life, according to a new study by researchers at Kaiser Permanente's Division of Research and the University of Kuopio in Finland. The study appears in the journal Dementia & Geriatric Cognitive Disorders.
The range of biomimetic approaches to promote bone growth that are at the core of current bone healing therapies need to more closely emulate natural regenerative mechanisms.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), and TransDerm, Inc., a biopharmaceutical company developing nucleic acid skin delivery technologies and therapeutics for skin disorders, announced today that they will collaborate on studying the potential utility of RXi's proprietary compounds in dermatology models.
› Verified 6 days ago
Blumenthal Nursing & Rehabilitation Center Location: 3724 Wireless Drive, Greensboro, North Carolina 27455 Phone: (336) 540-9991 | |
Accordius Health At Greensboro, Llc Location: 1201 Carolina Street, Greensboro, North Carolina 27401 Phone: (336) 522-5700 | |
Carolina Pines At Greensboro, Llc Location: 109 S Holden Rd, Greensboro, North Carolina 27407 Phone: (336) 522-5600 | |
Greenhaven Health And Rehabilitation Center Location: 801 Greenhaven Drive, Greensboro, North Carolina 27406 Phone: (336) 292-8371 | |
Friends Homes At Guilford Location: 925 New Garden Road, Greensboro, North Carolina 27410 Phone: (336) 292-8187 | |
Kindred Hospital East Greensboro Location: 2401 South Side Boulevard, Greensboro, North Carolina 27406 Phone: (336) 271-2800 |